Key Market Indicators
Antihypertensive medicine sales in Australia are set to reach $125.5 million by 2026. This is a growth of 2.6% each year, compared to the 8.2% growth seen since 1995. In 2021, Australia was the fourth largest market for antihypertensive medicines, behind Spain, Italy and Australia. Spain overtook Australia with sales of $108.2 million.
